Advancements in Cervical Cancer & the Role of Biomarkers

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Advancements in Cervical Cancer & the Role of Biomarkers

Program Information

Program Information

ReachMD Healthcare Image

Does a biomarker-based cytology test approved for use in the US have the potential to change the way we think about cervical cancer screening?

  • Sponsored by

  • Overview

    Cervical cancer is the fourth most common cancer in women worldwide, which makes it essential for us to keep ahead of advances in cervical cancer prevention—advances like a biomarker-based cytology test. Here to discuss this and other recent advancements in cervical cancer screening is Dr. Lee Shulman, the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University.

Facebook Comments

Schedule26 Oct 2021
Webpack App